Sign in
4

Changes in Ownership

RIGEL PHARMACEUTICALS INC Filed Acc 0000905148-24-003283

Options or other derivatives

  • EVP, Chief Commercial Officer acquired 8,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Santos David A · EVP, Chief Commercial Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-11-25 Grant or award : show line 1 in the form Employee Stock Option (right to buy) +8,000 8,000 D
Loading xslF345X05/form4.xml…